News
3d
GlobalData on MSNNiagen Bioscience signs exclusive licence deal for PD therapyNiagen Bioscience can either commercialise the drug candidate independently or sublicense to a strategic pharmaceutical ...
As health becomes more of a priority as we grow older, elivity is offering a way to aid healthy ageing with their line of ...
4d
WellBeing on MSNResurrecting the ageing liverSupport your ageing liver with diet, fasting and key nutrients to prevent fatty liver, hormone issues and decline.
23h
Mamamia on MSN'I get messages about my skincare routine all the time. So, here’s exactly what I use.'When I first got into skincare as a teenager, I never imagined I'd one day be helping people of all ages and skin types ...
Theoretical work has highlighted the potential of using devices in which spin-polarized carries are injected in single molecular magnets, and a few experiments have shown promising results. The ...
BenevolentAI to power small molecule drug discovery BenevolentAI has entered a two-year agreement with the MRC Technology to investigate new small molecule and antibody drug candidates.
Recursion Pharma has agreed to merge with rival AI-powered drug discovery firm Exscientia in an all-stock deal valued at $688 million ...
Rheumatoid arthritis (RA), a common chronic inflammatory illness, is still incurable, reducing the sufferers’ quality of life significantly. Adenosine 5′-triphosphate (ATP) and hypochlorous acid (HOCl ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results